Ascorbate exhibits anti-tumorigenic effects in pre-clinical models of endometrioid endometrial cancer

被引：0
|
作者：
John, Catherine [1 ]
Shen, Xiaochang [1 ]
Deng, Boer [1 ]
Zhao, Ziyi [1 ]
Zhou, Chunxiao [1 ]
Bae-Jump, Victoria [1 ]
Secord, Angeles Alvarez [2 ]
Batinic-Haberle, Ines [2 ]
Spasojevic, Ivan [2 ]
机构：
[1] Univ N Carolina, Chapel Hill, NC USA
[2] Duke Univ, Durham, NC USA
来源：
GYNECOLOGIC ONCOLOGY | 2023年 / 176卷
关键词：
D O I：
10.1016/j.ygyno.2023.06.516
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
043
引用
收藏
页码：S37 / S38
页数：2
相关论文
共 50 条
  • [21] Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer
    John, Catherine
    Xu, Guangxu
    Zhao, Ziyi
    Deng, Boer
    Shen, Xiaochang
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S76 - S77
  • [22] Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer
    Guo, Hui
    Zhong, Yan
    Jackson, Amanda L.
    Clark, Leslie H.
    Kilgore, Josh
    Zhang, Lu
    Han, Jianjun
    Sheng, Xiugui
    Gilliam, Timothy P.
    Gehrig, Paola A.
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    ONCOTARGET, 2016, 7 (15) : 20338 - 20356
  • [23] ONC201 has anti-tumorigenic effects in obesity-driven endometrial cancer
    Tucker, K.
    Staley, A.
    Pierce, S. R.
    Fan, Y.
    Yin, Y.
    Sun, W.
    Zhao, X.
    Zhang, Y.
    Lee, D.
    Prabhu, V.
    Zhou, C.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 49 - 49
  • [24] The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer
    Stine, Jessica E.
    Guo, Hui
    Sheng, Xiugui
    Han, Xiaoyun
    Schointuch, Monica N.
    Gilliam, Timothy P.
    Gehrig, Paola A.
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    ONCOTARGET, 2016, 7 (01) : 946 - 960
  • [25] Terminal differentiation and anti-tumorigenic effects of prolactin in breast cancer
    Ali, Suhad
    Hamam, Dana
    Liu, Xueqing
    Lebrun, Jean-Jacques
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [26] Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in vitro (vol 7, pg 2478, 2017)
    Jones, Hannah M.
    Fang, Ziwei
    Sun, Wenchuan
    Clark, Leslie H.
    Stine, Jessica E.
    Tran, Arthur-Quan
    Sullivan, Stephanie A.
    Gilliam, Timothy P.
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 8 (05): : 915 - 915
  • [27] SPR064, a pro-drug of paclitaxel, has anti-tumorigenic effects in endometrial cancer cell lines and mouse models
    Zhao, Xiaoling
    Kong, Weimin
    Tucker, Katherine
    Staley, Allison
    Fan, Yali
    Sun, Wenchuan
    Yin, Yajie
    Huang, Yu
    Fang, Ziwei
    Wang, Jiandong
    Sen, Somdutta
    Dugar, Sundeep
    Zhou, Chunxiao
    Jump, Victoria L.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (08): : 4264 - 4276
  • [28] NT1195, a novel biguanide, exhibits superior uterine penetration and anti-tumorigenic efficacy as compared to metformin/phenformin in endometrial cancer
    Tucker, Katherine
    Staley, Allison
    Fan, Yali
    Zhao, Xiaoling
    Yin, Yajie
    Fang, Ziwei
    Sun, Wenchuan
    Batchelor, Kenneth
    Livingston, Nick
    Zhou, Chunziao
    Bae-Jump, Victoria
    CANCER RESEARCH, 2019, 79 (13)
  • [29] Pre-clinical cancer models
    Jackstadt, R. F.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S115 - S115
  • [30] Simvastatin has anti-tumorigenic effects in endometrial cancer via reversal of obesity-driven upregulation of lipid biosynthesis
    West, L.
    Clark, L. H.
    Pierce, S. R.
    Yin, Y.
    Fang, Z.
    Lee, D.
    Zhou, C.
    Bae-Jump, V. L.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 16 - 16
12345